| __timestamp | Amphastar Pharmaceuticals, Inc. | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 210461000 | 4320000 |
| Thursday, January 1, 2015 | 251519000 | 2538000 |
| Friday, January 1, 2016 | 255165000 | 3337000 |
| Sunday, January 1, 2017 | 240175000 | 4003000 |
| Monday, January 1, 2018 | 294666000 | 8386000 |
| Tuesday, January 1, 2019 | 322357000 | 4461000 |
| Wednesday, January 1, 2020 | 349846000 | 1050000 |
| Friday, January 1, 2021 | 437768000 | 2963000 |
| Saturday, January 1, 2022 | 498987000 | 1772000 |
| Sunday, January 1, 2023 | 644395000 | 314000 |
Unlocking the unknown
In the dynamic world of biotechnology, Amphastar Pharmaceuticals, Inc. and Viridian Therapeutics, Inc. present a fascinating study in contrasts. Over the past decade, Amphastar has demonstrated a robust revenue growth trajectory, with a remarkable increase of over 200% from 2014 to 2023. Starting at approximately $210 million in 2014, Amphastar's revenue surged to nearly $645 million by 2023, reflecting its strategic market positioning and successful product lines.
Conversely, Viridian Therapeutics, Inc. has faced a more challenging path. Despite a promising start with revenues peaking at around $8.4 million in 2018, the company saw a significant decline, with revenues dropping to just $314,000 in 2023. This stark contrast highlights the volatile nature of the biotech industry, where innovation and market adaptation are key to survival and growth.
Revenue Insights: Pfizer Inc. and Amphastar Pharmaceuticals, Inc. Performance Compared
Regeneron Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.: Examining Key Revenue Metrics
GSK plc vs Amphastar Pharmaceuticals, Inc.: Examining Key Revenue Metrics
Bio-Techne Corporation vs Amphastar Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Walgreens Boots Alliance, Inc. and Amphastar Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Exelixis, Inc. vs Amphastar Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Jazz Pharmaceuticals plc vs Amphastar Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Annual Revenue Comparison: Lantheus Holdings, Inc. vs Viridian Therapeutics, Inc.
Ionis Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.: Examining Key Revenue Metrics
TG Therapeutics, Inc. vs Amphastar Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Vericel Corporation and Viridian Therapeutics, Inc.: A Comprehensive Revenue Analysis
Breaking Down Revenue Trends: ImmunityBio, Inc. vs Viridian Therapeutics, Inc.